Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Mitapivat Sulfate in Adult Patients With Erythrocyte Membranopathies

NCT05935202 is registered in ClinicalTrials.gov with EuroBloodNet Association as lead sponsor.

NCT NCT05935202
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05935202 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Mitapivat Sulfate in Adult Patients With Erythrocyte Membranopathies
Lead sponsor
EuroBloodNet Association
Phase
Phase 2
Overall status
Not yet recruiting
Start date
December 21, 2023
Completion date
December 15, 2026
Enrollment
25 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hereditary red blood cell disorder (disorder)